An emerging disease threat : how the U.S. is responding to COVID-19, the novel coronavirus : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixteenth Congress, second session on examining an emerging disease threat, focusing on how the United States is responding to COVID-19, the novel coronavirus, March 3, 2020.

Format:

Book

Government document

Author/Creator:

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.

Series:

United States. Congress. Senate. S. hrg. ; 116-504.

S. hrg. ; 116-504

Language:

English

Subjects (All):

COVID-19 (Disease)--Government policy--United States.

COVID-19 (Disease).

COVID-19 Pandemic, 2020-2023--United States.

COVID-19 Pandemic, 2020-2023.

Public health--United States.

Public health.

COVID-19 (Disease)--Government policy.

United States.

Genre:

Legislative hearings

Legislative hearings.

Physical Description:

1 online resource (iii, 57 pages).

Other Title:

How the U.S. is responding to COVID-19, the novel coronavirus

Place of Publication:

Washington : U.S. Government Publishing Office, 2021.

Participant:

Hearing witnesses: Statement of Schuchat, Anne, M.D., Principal Deputy Director, Centers for Disease Control and Prevention, Atlanta, GA; Statement of Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Statement of Kadlec, Robert, M.D., Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC; Statement of Hahn, Stephen, M.D., Commissioner, U.S. Food and Drug Administration, Silver Spring, MD.

Notes:

Includes bibliographical references.

Date of hearing: 2020-03-03.

Description based on online resource; title from PDF title page (govinfo, viewed Dec. 15, 2021).

Other Format:

Print version: United States. Congress. Emerging disease threat

OCLC:

1288683477

Publisher Number:

45-217 (GPO jacket number)